EZH2 and breast carcinoma: Similarly to the case of an inverse correlation between oncogenic EZH2 and tumor-suppressive RORα in breast cancer, we speculate that the potential oncogenic function of G9a might be augmented by the degradation of FOXO1, which is a known tumor suppressor.